SUSI ROGER E. (CEO, PRESIDENT, CHAIRMAN) sold 0.2% of their position (5K shares) of IRADIMED CORP on the open market
Open‑market sale worth $488.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/30/2025ACC: 0001613801-25-000042
DirectorOfficer10% Owner· CEO, PRESIDENT, CHAIRMAN
Since Mar 2026
-5K
Net shares
Net seller
$488.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
5K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−4.90K
Price / share
$97.65
Trade value
$478.39K
% of position
0.2%
12/29/2025
2.29M→2.28M
Common Stock
Indirect
Shares
−101.00
Price / share
$98.31
Trade value
$9.93K
% of position
0.0%
12/29/2025
2.28M→2.28M
Total
Net shares
−5K
Net value
-$488.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/29/2025 | S · Sale | −4.90K | $97.65 | $478.39K | 0.2% | 2.29M | 2.28M |
| Common Stock Indirect | 12/29/2025 | S · Sale | −101.00 | $98.31 | $9.93K | 0.0% | 2.28M | 2.28M |
| Total | −5K | -$488.32K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned162.95K
Common Stock
IndirectShares owned2.06M
Total
2.23M indirect2.23M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 162.95K | Indirect |
| Common Stock | 2.06M | Indirect |
| Total | 2.23M | 2.23M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported